← Eichor
Study identifier: NCT05872737 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

FAB Programme for Parents of Children With NDD

Condition: Autism Spectrum Disorder · Attention Deficit Hyperactivity Disorder · Neurodevelopmental Disorders  ·  Sponsor: Chinese University of Hong Kong

PhaseNA
Planned participants154
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

The study aims to examine the effectiveness of a psychotherapy approach called Facilitator-guided Acceptance and Commitment Bibliotherapy (FAB) in improving the psychological health of parents of young children with neurodevelopmental disorders (NDD) and reducing the emotional and behavioral symptoms of NDD children. The study will involve 154 Cantonese-speaking parents of children aged 2-6 years diagnosed with NDD in Hong Kong. The study hopes to find that FAB can improve parent-child dyads' health outcomes by enhancing psychological flexibility, parental psychological health, and mindful parenting skills.

This description comes directly from the study's public registry record.

Talk to the study team

Yuen Yu CHONG, PhD  ·  (852) 3943 0665  ·  conniechong@cuhk.edu.hk

Always discuss trial participation with your own doctor first.

Locations (2)

Hong Kong Sheng Kung Hui Welfare Council LimitedHong Kong, Hong KongRecruiting
The Chinese University of Hong KongShatin, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05872737